Global Liposomes Drug Delivery Market Data Download UPDATED
Global Liposomes Drug Delivery Market Data Download
Leading Opinion
Positioning metal-organic framework nanoparticles within the context of drug delivery – A comparison with mesoporous silica nanoparticles and dendrimersAbstruse
Nanotechnology enables the creation of delivery vehicles able to overcome physiologically imposed barriers, assuasive new approaches for reducing the unwanted side furnishings of systemic delivery of drug, increasing targeting efficiency and so improving therapy efficacy. Owing to the considerable advances in material sciences and pharmaceutics, a broad range of different inorganic or organic drug nanocarriers have been developed. Furthermore, researchers have shown that the combination of inorganic and organic chemistries in one unmarried cloth, named metallic-organic framework (MOF), offers structural designability at the molecular level together with tunable porosity and chemical functionalisability. While the MOF size can be controlled at the nanometer calibration, these features are of paramount interest in the development of the next generation of drug delivery systems. After a brusk state-of-the-art about MOF engineering science and within the drug delivery context, this paper discusses the benefits of using MOF nanoparticles compared to dendrimers and mesoporous silica nanoparticles in order to understand the challenges that must however exist overcome.
Introduction
In light of the increasing number of publications over the last decade, metal-organic frameworks (MOFs), as well known as porous coordination polymers, have emerged as a promising new grade of porous materials. While their potential applications in various fields, ranging from gas storage to free energy technologies including catalysis, take been highlighted and reported in several articles and themed problems [1], [ii], [three], [4], [five], [6], [seven], MOF materials, and in particular their nanometric counterparts, notwithstanding take to exist discussed relative to other fabric classes in terms of their construction-to-performance relationships. This perspective article thus aims at describing the benefits of using MOF nanoparticles (MOF NPs or nanoMOFs) in the field of biomedicine, and putting into perspective their properties in the context of the ones of other NPs.
The use of nanoparticles (NPs) relies on their properties that fundamentally differ from those of the corresponding three-dimensional infinite solids [eight]. These properties are size- and surface-dependent and kickoff to get pregnant at a length scale below 100 nm, which defines the arbitrary just scientific accepted definition of nanomaterials and NPs in particular. The virtually important feature of NPs is their large external surface area, i.due east. their high surface-to-volume ratio, which dominates NPs physicochemical backdrop. As a consequence of an increased number of surface atoms, NPs are typically highly chemically reactive, have a lower melting indicate in comparison to the bulk material, and tend to form aggregates [8]. The NPs surface interface likewise drives the interactions of NPs with their environment. This is a valuable property equally the surface-interface can exist engineered to ameliorate chemical and colloidal stability for targeting specific problems, as for case concomitant transport and delivery of bioactive molecules, which are typical tasks defining the nanocarrier concept [9], [10], [11], [12], [13], [14], [15], [16], [17], [xviii], [19], [20], [21]. The unlike nanomaterial classes developed to date tin can be categorized into NP either purely organic nanosystems including liposomes, dendrimers, micelles, and polymeric capsules, or purely inorganic NPs such equally quantum dots, noble metal NPs, fe oxide NPs, silica NPs and upconversion NPs [9], [x], [11], [18]. In general inorganic NPs require an organic surface coating warranting for colloidal stability, as in the context of biological media also inorganic NPs inevitable will comprise organic molecules adsorbed to their surface [8], [22]. MOF NPs or nanoMOFs define a new course of hybrid nanomaterials as they consist of inorganic edifice units (e.chiliad. metal oxide clusters) covalently continued by organic building units (e.g. organic linkers) at the nanometer level [23], [24], [25], [26], [27], [28], [29], [xxx], [31]. Hence, MOF NPs combine the richness of bulk MOF chemical science with the benign surface- and size-dependent properties of the nanoworld (Fig. 1). Bringing together both of these worlds leads to a flourishing interdisciplinary field of research based on the interconnection of chemical science, physics, and material sciences, which can have diverse practical outcomes relevant to in various sectors of applications and in particular in biomedicine.
Section snippets
Magic bullet concept and scope of the paper
The development of efficient drug delivery systems is an of import topic of biomedical research in order to ensure a quicker and forceful therapeutic outcome. Any the assistants route used to deliver the drug, i.east. oral, nasal, skin, pulmonary or intravenous, drugs in general have to cantankerous multiple biological barriers in order to achieve their intended site of activeness (Fig. 2) [32], [33]. Furthermore, systemic drug assistants suffers from critical issues as poor solubility, limited
MOF nanoparticles as future nanocarriers
MOFs are hybrid materials constructed via strong metal-ligand covalent bonds betwixt inorganic clusters and organic linkers, which are organized in a periodic way to create porous and crystalline 3-dimensional framework (Fig. 3) [5], [vi], [46], [47]. In full general, MOFs can be made of numerous metallic ions of the periodic table, especially those that are di-, tri- or tetravalent and that form inorganic clusters during the synthesis (Fig. three) [48]. The organic linker, for its part, is preformed
Conclusion and outlook
Taken all together, MOF NPs appear as a very promising drug delivery platform that still needs to be fully exploited to get closer to the concept of a "magic bullet" with universally improved backdrop as compared to other NP classes used in drug delivery. Their cardinal reward is their hybrid nature relying on the synergistic combination of inorganic and organic chemistry that allows very high porosities and the incorporation of a big variety of functional groups. On one hand, their assembly
Acknowledgements
Parts of this work were funded by the European Commission (projection FutureNanoNeeds to WJP). SW is grateful for financial back up from the Deutsche Forschungsgemeinschaft through DFG-project WU 622/4-i. ML is grateful for the financial support of a Concerted Enquiry Action from the University of Liège, Kingdom of belgium (CRA2015 – Projection icFlow). Finally, the authors would like to thank Prof. Omar M. Yaghi (UC Berkeley) for his valuable constructive comments.
References (193)
- et al.
Dendrimers—branching out from curiosities into new technologies
Prog. Polym. Sci.
(1998)
- et al.
Mesoporous silica nanoparticles in medicine-Contempo advances
Adv. Drug Deliv. Rev.
(2013)
- et al.
Synthesis and characterization of large mesoporous silica SBA-xv sheets with ordered accessible 18 nm pores
Mater. Lett.
(2009)
-
Dendrimers as versatile platform in drug delivery applications
Eur. J. Pharm. Biopharm.
(2009)
- et al.
Dendrimers: emerging polymers for drug-delivery systems
Eur. J. Pharm. Sci.
(2009)
- et al.
Application of metal and metal oxide [email protected]
Coord. Chem. Rev.
(2016)
- et al.
Targeted anticancer therapy: overexpressed receptors and nanotechnology
Clin. Chim. Acta
(2014)
-
Doxil – the outset FDA-canonical nano-drug: lessons learned
J. Command. Release
(2012)
- et al.
Protein nanoparticles equally drug carriers in clinical medicine
Adv. Drug Deliv. Rev.
(2008)
- et al.
Country-of-the-art in blueprint rules for drug commitment platforms: lessons learned from FDA-approved nanomedicines
J. Control. Release
(2014)
Nanoparticles in cellular drug delivery
Bioorg. Med. Chem.
(2009)
Special issue: new generations of porous metal-organic frameworks
Microporous Mesoporous Mater.
(2015)
Flexibility and disorder in metallic–organic frameworks
Dalt. Trans.
(2016)
The pervasive chemical science of metal-organic frameworks
Chem. Soc. Rev.
(2009)
Metal-Organic frameworks and hybrid materials: from fundamentals to applications
CrystEngComm
(2015)
Introduction to metal-organic frameworks
Chem. Rev.
(2012)
Metal–organic frameworks (MOFs)
Chem. Soc. Rev.
(2014)
The hole story
Nature
(2015)
Nanoparticulate functional materials
Angew. Chem. – Int. Ed.
(2010)
Nanomedicine
Chem. Soc. Rev.
(2012)
Introduction: nanoparticles in medicine
Chem. Rev.
(2015)
Guest editorial- theranostic nanomedicine
Acc. Chem. Res.
(2011)
Drug commitment systems: entering the mainstream
Scientific discipline
(2004)
Impact of nanotechnology on hair attributes
ACS Nano
(2009)
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
Nat. Rev. Drug Discov.
(2014)
Stimuli-responsive nanocarriers for drug delivery
Nat. Mater.
(2013)
Mesoporous silica nanoparticles in biomedical applications
Chem. Soc. Rev.
(2012)
Nanocarriers as an emerging platform for cancer therapy
Nat. Nanotechnol.
(2007)
The land of nanoparticle-based nanoscience and biotechnology: progress, promises, and challenges
ACS Nano
(2012)
Treating metastatic cancer with nanotechnology
Nat. Rev. Cancer
(2011)
The challenge to chronicle the physicochemical backdrop of colloidal nanoparticles to their cytotoxicity
Acc. Chem. Res.
(2012)
Infinite coordination polymer nano- and microparticle structures
Chem. Soc. Rev.
(2009)
Nanoscale metal–organic materials
Chem. Soc. Rev.
(2011)
Metallic-organic frameworks in biomedicine
Chem. Rev.
(2012)
MOF positioning engineering science and device fabrication
Chem. Soc. Rev.
(2014)
Nanomedicine applications of hybrid nanomaterials congenital from metal-ligand coordination bonds: nanoscale metal-organic frameworks and nanoscale coordination polymers
Chem. Rev.
(2015)
Nanostructured metal-organic frameworks and their bio-related applications
Coord. Chem. Rev.
(2015)
Cooperative effects at the interface of nanocrystalline metal–organic frameworks
Nano Res.
(2016)
Structuring of metallic–organic frameworks at the mesoscopic/macroscopic scale
Chem. Soc. Rev.
(2014)
Trapping metallic-organic framework nanocrystals: an in-situ fourth dimension-resolved lite scattering report on the crystal growth of MOF-5 in solution
J. Am. Chem. Soc.
(2007)
Challenges in development of nanoparticle-based therapeutics
AAPS J.
(2012)
Principles of nanoparticle pattern for overcoming biological barriers to drug delivery
Nat. Biotechnol.
(2015)
Hybrid smart mesoporous silica nanoparticles for theranostics
Nanomedicine
(2015)
Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery
Chem. Mater.
(2014)
Albumin-leap formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Int. J. Nanomed.
(2009)
Facing the truth near nanotechnology in drug delivery
ACS Nano
(2013)
Strategies in the design of nanoparticles for therapeutic applications
Nat. Rev. Drug Discov.
(2010)
Polymers for siRNA commitment: inspired past viruses to be targeted, dynamic, and precise
Acc. Chem. Res.
(2012)
Environmental health and safe considerations for nanotechnology
Acc. Chem. Res.
(2013)
Toxic potential of materials at the nanolevel
Scientific discipline
(2006)
Cited by (170)
Recommended articles (6)
© 2017 Elsevier Ltd. All rights reserved.
DOWNLOAD HERE
Posted by: farrenasted1989.blogspot.com
Post a Comment for "Global Liposomes Drug Delivery Market Data Download UPDATED"